Cite

    Malherbe, J. et al. (2016). Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms. Journal of clinical pathology. 69 (2), pp. 155-163. [Online].